In the model, ITGA3 and TNFSF10 were identified as risk factors, with high expression adversely affecting the prognosis of PC patients, while CDK11A and RHOG were protective factors, with high expression being favorable for tumor prognosis. This evidence concerns the gene ITGA3 and neoplasm.